SNAP-8
Acetyl Octapeptide-3 | Anti-Wrinkle & Expression Line Peptide
On this page
What is SNAP-8?
SNAP-8 is a lab-made, eight-amino-acid peptide developed as a topical (skin-applied) alternative to injectable neuromodulators for softening the appearance of expression lines. It works by interfering with the same signaling machinery that triggers small muscle contractions in the face, and it's studied in clinical trials as a cosmetic-ingredient peptide rather than an injectable drug. It's sold here strictly as a research chemical for laboratory and formulation study, not as a finished cosmetic product.
Key terms:
SNAP-8 is a synthetic acetylated octapeptide with c-terminal amidation.
SNAP-8 (Acetyl Octapeptide-3) is a lab-made peptide of eight amino acids. It was developed as a skin-applied alternative to botulinum toxin for softening dynamic facial wrinkles. It copies one end of the SNAP-25 protein and competes with it, blocking assembly of the SNARE complex, the machinery nerve endings use to release acetylcholine. Less acetylcholine means fewer small muscle contractions. Clinical studies reported up to 63% reduction in wrinkle depth with consistent topical use.
Key research areas
- Non-invasive alternative to Botox
- Reduces expression lines and dynamic wrinkles by up to 63%
- Safe for sensitive skin areas including around the eyes
- No recovery time required
Researched dosing
This table shows the topical concentrations and application frequencies researchers have used in SNAP-8 study designs, presented as research methodology rather than a personal skincare routine.
| Phase | Dose | Frequency | Route |
|---|---|---|---|
| General longevity studies | 3-5% concentration | 2x daily | Topical serum/cream |
| Higher-concentration wrinkle studies | 5-10% concentration | 2x daily | Targeted application |
| Eye-area studies | 3-5% concentration | 2x daily | Eye cream/serum |
| Forehead-line studies | 5-10% concentration | 2x daily | Direct application |
| Early-use studies | 3% concentration | 1-2x daily | Daily moisturizer |
| Combined peptide protocol | 3-5% with other peptides | 2x daily | Multi-peptide serum |
How it works
At the cell level, SNAP-8 research looks at how the peptide competes with a natural protein (SNAP-25) for a role in the signaling that triggers small facial-muscle contractions — the terms below just name that pathway.
SNAP-8 mimics the N-terminal end of SNAP-25 protein and competes for binding sites in the SNARE complex. This destabilization prevents efficient neurotransmitter release at the neuromuscular junction, reducing muscle contractions and preventing formation of expression lines and wrinkles
Molecular data
These figures — molecular weight, sequence, chain length — are the chemistry fingerprint researchers use to confirm a SNAP-8 sample's identity; the added end-cap (amidation) is a common stability trick in cosmetic peptides.
- Weight
- 1075.16 Da
- Length
- 8 amino acids
- Type
- Synthetic Acetylated octapeptide with C-terminal amidation
Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2
Research applications
This section lists the research areas — expression-line and skin research chief among them — that scientists have studied for SNAP-8 in clinical trials of topical formulations, summarizing what's been studied in the literature, not medical claims about people.
Anti Wrinkle
Clinical studies demonstrate up to 63% reduction in wrinkle depth around the eyes and forehead with consistent application over 28 days. Effectively targets horizontal forehead lines caused by repetitive muscle contractions from raising eyebrows and facial expressions. Reduces periorbital wrinkles (crow's feet) through localized muscle relaxation without affecting natural facial expressions.
Muscle Relaxation
Reduces neuromuscular junction activity by competing with SNAP-25 for SNARE complex binding, leading to reduced acetylcholine release and decreased muscle contraction intensity.
Skin Health
Complementary skin health benefits when used alongside hydrating ingredients, contributing to overall skin quality improvement and maintenance of results with consistent use.
Dosage reference
- Doses used in research
- 3–10% concentration in topical research formulations.
- Frequency in studies
- Twice daily (morning and evening)
- Handling
- Reconstituted solution — research use only; not for administration
- Timeline reported in studies
- 7 days: early smoothing; 28 days: significant reduction; 8+ weeks: maximum results
- Storage
- Solution at 4°C (refrigerated); powder at room temperature in cool, dark place
- Cycle length
- Continuous use - effects require ongoing application
- Break between cycles
- No cycling required - safe for long-term continuous use
Interactions
This list shows which other cosmetic peptides and skincare ingredients are studied alongside SNAP-8, and flags a few (like strong acids) that call for careful timing.
Reconstitution & storage
This describes how a research-grade SNAP-8 sample is dissolved into a topical formulation at a study-relevant concentration, rather than an injectable mixing procedure.
- If using powder: dissolve in distilled water or add to serum base at 3-10% concentration
- Store the reconstituted solution refrigerated (2–8°C), labeled with the date and concentration, for laboratory research use only.
Lyophilized: Room temperature, cool dark place, use within Per manufacturer specification
Reconstituted: 2-6°C, use within Per formulation guidelines; solution at 4°C (refrigerated)
Quality indicators
These are the visual and formulation checks researchers and formulators use to confirm a SNAP-8 solution hasn't degraded before it's used in a study.
Clear, colorless solution - SNAP-8 solution should be clear and colorless to slightly yellowish with no visible particles or cloudiness
pH between 3.0-5.0 - Optimal pH range for stability and skin compatibility. Products outside this range may indicate degradation
Proper packaging - Should be in airless pump, dark glass, or UV-protected container to prevent degradation from light and air
Gradual visible results - Quality SNAP-8 produces subtle but measurable wrinkle reduction over 2-4 weeks of consistent use
Concentration verification - Many commercial products contain subtherapeutic concentrations. Look for products specifying 3-10% SNAP-8 solution
Cloudy or discolored solution - Indicates degradation, contamination, or improper storage - product should be discarded
Strong odor or unusual smell - SNAP-8 should be essentially odorless. Strong odors suggest contamination or degradation
What to expect
This timeline reflects what the published research literature reports at each stage of topical use — research context for comparing studies, not a personal-results promise.
Skin may feel slightly smoother; minimal visible changes as peptide begins accumulating in tissue
Initial reduction in fine lines, especially with facial expressions; skin appears more relaxed
Significant wrinkle depth reduction (up to 35% average); expression lines less pronounced
Maximum efficacy achieved (up to 63% reduction); forehead and eye area show notable improvement
Safety notes
This section covers handling cautions and regulatory notes for SNAP-8 — it's used as a cosmetic ingredient rather than an approved drug, and this context is for research and formulation purposes, not medical advice.
- Perform patch test on inner arm 24 hours before first facial use to check for sensitivity
- Avoid combining with strong acids (AHAs/BHAs) in the same application - use at different times
- Not intended for use during pregnancy or breastfeeding (insufficient safety data)
- Discontinue use if persistent irritation, redness, or allergic reaction occurs
- Not FDA approved as a drug; used as cosmetic ingredient
- Cosmetic peptide - generally recognized as safe for topical use at studied concentrations
Regulatory status
- Not approved by the FDA for any indication.
- Supplied and described for laboratory research use only — not for human or veterinary use.
Community data
Community Insights
Based on data the community reported. Not clinical proof.
References
Recent comprehensive review in MDPI Biomolecules covering emerging peptide candidates for skin senescence prevention, including detailed analysis of neurotransmitter-modulating peptides like SNAP-8 (Peptides for Skin Senescence Prevention, 2025)
Clinical safety and efficacy evaluation of dissolving microneedle patches delivering anti-wrinkle peptides including SNAP-8, demonstrating enhanced delivery and wrinkle reduction compared to topical application alone
First multicenter randomized, placebo-controlled trial in 60 Chinese subjects evaluating Argireline (parent compound of SNAP-8): total anti-wrinkle efficiency 48.9% in treatment group vs 0% placebo, significant wrinkle depth reduction (P<0.01)